ライフサイエンスコーパス: respiratory tract disease

1 ng invasive mechanical ventilation for lower respiratory tract disease.

2 y explain why MERS is characterized by lower respiratory tract disease.

3 ion in human infants at risk of severe lower respiratory tract disease.

4 ory tract and is a common cause of localized respiratory tract disease.

5 primary etiological agent of childhood lower respiratory tract disease.

6 y pathogen that causes acute upper and lower respiratory tract disease.

7 en with acute respiratory failure from lower respiratory tract disease.

8 in respiratory specimens of individuals with respiratory tract disease.

9 g the severity of influenza-associated lower respiratory tract disease.

10 icant advances in the investigation of human respiratory tract disease.

11 responsible for a substantial proportion of respiratory tract disease.

12 the respiratory secretions of children with respiratory tract disease.

13 yxovirus that is an important cause of acute respiratory tract disease.

14 m that is commonly associated with localized respiratory tract disease.

15 l complex associations with asthma and other respiratory tract diseases.

16 respiratory viruses (RVs) in suspected lower respiratory tract disease, 72 paired NP and bronchoalveo

17 st the two leading viral agents of pediatric respiratory tract disease, a bivalent vaccine whose atte

18 s (RSV) is an important cause of acute lower respiratory tract disease among the elderly, but nationa

19 en with acute respiratory failure from lower respiratory tract disease, an extubation readiness test,

20 lus influenzae is a major cause of localized respiratory tract disease and initiates infection by col

21 uenzae (NTHi) is a common cause of localized respiratory tract disease and initiates infection by col

22 Haemophilus influenzae is a common cause of respiratory tract disease and initiates infection by col

23 V antigens are believed to cause exaggerated respiratory tract disease and may also contribute to unw

24 URTI recovered without progression to lower respiratory tract disease, and 10 (83%) of the 12 patien

25 Bordetella avium causes an upper respiratory tract disease (bordetellosis) in avian speci

26 Bordetella avium causes an upper-respiratory-tract disease called bordetellosis in birds.

27 Lower respiratory tract disease can manifest itself as airflow

28 ld be used prophylactically to prevent lower respiratory tract disease caused by hMPV.

29 tes to protect infants from the severe lower respiratory tract disease caused by HPIV3.

30 Lower respiratory tract disease caused by respiratory syncytia

31 cines, antivirals, and other drugs acting on respiratory tract disease caused by RSV.

32 ll cocultures using Moraxella catarrhalis, a respiratory tract disease-causing bacterium, as a biolog

33 S coronavirus (SARS-CoV) causes severe acute respiratory tract disease characterized by diffuse alveo

34 is an important etiologic agent of pediatric respiratory tract disease, could be enhanced by expressi

35 .001), while hospitalization rates for lower respiratory tract diseases excluding bronchiolitis did n

36 responsible for a substantial proportion of respiratory tract diseases have not been identified.

37 respiratory tract and then progress to lower respiratory tract disease in a subset of patients.

38 is the most important cause of severe lower-respiratory tract disease in calves and young children,

39 ) NL63, associated with both upper and lower respiratory tract disease in children and adults worldwi

40 gen, is associated with both upper and lower respiratory tract disease in children and adults.

41 metapneumovirus (hMPV) is a leading cause of respiratory tract disease in children and is associated

42 e is a major cause of otitis media and other respiratory tract disease in children.

43 is an important pathogen causing acute lower respiratory tract disease in children.

44 al virus (RSV) is the leading cause of lower respiratory tract disease in children.

45 identified as a significant cause of serious respiratory tract disease in humans.

46 ) is an important viral agent causing severe respiratory tract disease in infants and children as wel

47 us (RSV) is the leading viral cause of lower respiratory tract disease in infants and children worldw

48 irus, is a major viral cause of severe lower respiratory tract disease in infants and children.

49 s (RSV) is the most important cause of lower respiratory tract disease in infants and children.

50 is the most significant viral cause of lower respiratory tract disease in infants and children.

51 irus (hRSV) is responsible for serious lower respiratory tract disease in infants and in older adults

52 virus (RSV) is a major cause of severe lower respiratory tract disease in infants and the elderly, bu

53 lthough a prominent cause of upper and lower respiratory tract disease in infants and the elderly, cl

54 st and second leading viral agents of severe respiratory tract disease in infants and young children

55 al virus (RSV) is the leading cause of lower respiratory tract disease in infants and young children

56 respiratory virus that causes serious lower respiratory tract disease in infants and young children

57 rus type 1 (HPIV1) is a significant cause of respiratory tract disease in infants and young children

58 al virus (RSV) is the leading cause of lower respiratory tract disease in infants and young children

59 and is associated with both upper and lower respiratory tract disease in infants and young children.

60 ause of morbidity and life-threatening lower respiratory tract disease in infants and young children.

61 and, if so, whether they are associated with respiratory tract disease in infants and young children.

62 may account for a significant proportion of respiratory tract disease in infants and young children.

63 ry etiologic agent of serious epidemic lower respiratory tract disease in infants, immunosuppressed p

64 cytial virus (RSV), the major cause of lower respiratory tract disease in infants, is thought to infe

65 is the most important viral cause of severe respiratory tract disease in infants.

66 es to a herpesvirus associated with an upper respiratory tract disease in Mediterranean tortoises [sp

67 a major cause of morbidity and severe lower respiratory tract disease in the elderly and very young,

68 a in immunocompetent children and with lower respiratory tract disease in the immunocompromised host.

69 irus, is a major etiological agent for lower respiratory tract disease in young children that can man

70 cause of otitis media in children and lower respiratory tract diseases in adults.

71 virus type 3 (HPIV3), a major cause of lower respiratory tract diseases in infants, and the emerging

72 ed for a small but significant proportion of respiratory-tract disease in infants and children.

73 nd resistance to treatment of multiple human respiratory tract diseases including otitis media, chron

74 The prevalence of aspirin-exacerbated respiratory tract disease is approximately 10% and for a

75 rder, cardiovascular diseases, chronic lower respiratory tract diseases, liver cirrhosis, and spinal

76 Respiratory syncytial virus (RSV) lower respiratory tract disease (LRD) is a life-threatening co

77 yses, more patients with 2009 H1N1 had lower respiratory tract disease (LRD), hypoxemia, and prolonge

78 a increased the risk of progression to lower respiratory tract disease (LRD), hypoxemia, respiratory

79 d virus (75%) had a medically attended lower respiratory tract disease (LRD).

80 nsplantation (HCT), frequently causing lower respiratory tract disease (LRTD).

81 emophilus influenzae, a major cause of lower respiratory tract diseases, must cope with a range of el

82 The lower respiratory tract disease observed in this monkey model

83 Respiratory tract disease occurs when NTHi adhere to or

84 ognized as a causative agent in this complex respiratory tract disease of cattle.

85 e acute respiratory syndrome (SARS), a lower respiratory tract disease of humans that was first repor

86 s frequently observed in patients with upper respiratory tract disease only and more frequently in pa

87 stic techniques and is associated with lower respiratory tract disease, particularly in children.

88 may be the etiological agent responsible for respiratory tract disease, particularly in young childre

89 ich are associated with both upper and lower respiratory tract disease, particularly in young childre

90 acute otitis media, and 8 episodes of lower respiratory tract disease per 1000 children yearly.

91 Viral respiratory tract diseases pose serious public health pr

92 ially isolated from a young child with lower respiratory tract disease, represents a group of newly d

93 ion on the contribution of HMPV to pediatric respiratory tract disease suggests that it will be impor

94 able Haemophilus influenzae (NTHI) can cause respiratory tract diseases that include otitis media, si

95 Upper respiratory tract disease (URTD) has been observed in a

96 in nasopharyngeal colonization and localized respiratory tract disease, we assessed their expression

97 old listing bronchiolitis, pneumonia, or any respiratory tract disease were examined.

98 Rates of acute otitis media and lower respiratory tract disease were highest among children ag

99 nfluenzae is an important cause of localized respiratory tract disease, which begins with colonizatio

100 tial virus (RSV) is a leading cause of lower respiratory tract disease, which causes high rates of mo

101 us (HRV) is a major cause of upper and lower respiratory tract disease worldwide and displays conside

102 st important viral agent of severe pediatric respiratory tract disease worldwide, but it lacks a lice

103 ncytial virus (RSV) is an important cause of respiratory tract disease worldwide, especially in the p

104 fied in 2001, is a causative agent of severe respiratory tract disease worldwide.

105 nfluenza A virus (IAV) is a leading cause of respiratory tract disease worldwide.

106 he most important agent of serious pediatric respiratory tract disease worldwide.

107 ond most important viral agents of pediatric respiratory tract disease worldwide.

108 t important viral agent of serious pediatric respiratory-tract disease worldwide.